Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca J Richter

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|March 12, 2010
Paraoxonase 1 status as a risk factor for disease or exposureRebecca J Richter, Gail P Jarvik, Clement E Furlong
Circulation. Cardiovascular Genetics|December 25, 2009
Determination of paraoxonase 1 status without the use of toxic organophosphate substratesRebecca J Richter, Gail P Jarvik, Clement E Furlong
Toxicology and Applied Pharmacology|December 17, 2008
Paraoxonase 1 (PON1) status and substrate hydrolysisRebecca J Richter, Gail P Jarvik, Clement E Furlong
Current Protocols|January 23, 2021
Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate SubstratesJudit Marsillach, Rebecca J Richter, Lucio G Costa, et al.
Pharmacogenetics and Genomics|February 24, 2006
PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivityClement E Furlong, Nina Holland, Rebecca J Richter, et al.
Chemico-Biological Interactions|November 6, 2012
Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposuresJudit Marsillach, Edward J Hsieh, Rebecca J Richter, et al.
Current Protocols in Toxicology|October 15, 2010
Determination of paraoxonase 1 status and genotypes at specific polymorphic sitesRebecca J Richter, Rachel L Jampsa, Gail P Jarvik, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 10, 2003
Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicityLucio G Costa, Rebecca J Richter, Wan-Fen Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2008
Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoningRichard C Stevens, Stephanie M Suzuki, Toby B Cole, et al.
Pharmacogenetics|May 2, 2003
Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 statusGail P Jarvik, Rachel Jampsa, Rebecca J Richter, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|March 12, 2010
Paraoxonase 1 status as a risk factor for disease or exposureRebecca J Richter, Gail P Jarvik, Clement E Furlong
Circulation. Cardiovascular Genetics|December 25, 2009
Determination of paraoxonase 1 status without the use of toxic organophosphate substratesRebecca J Richter, Gail P Jarvik, Clement E Furlong
Toxicology and Applied Pharmacology|December 17, 2008
Paraoxonase 1 (PON1) status and substrate hydrolysisRebecca J Richter, Gail P Jarvik, Clement E Furlong
Current Protocols|January 23, 2021
Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate SubstratesJudit Marsillach, Rebecca J Richter, Lucio G Costa, et al.
Pharmacogenetics and Genomics|February 24, 2006
PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivityClement E Furlong, Nina Holland, Rebecca J Richter, et al.
Chemico-Biological Interactions|November 6, 2012
Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposuresJudit Marsillach, Edward J Hsieh, Rebecca J Richter, et al.
Current Protocols in Toxicology|October 15, 2010
Determination of paraoxonase 1 status and genotypes at specific polymorphic sitesRebecca J Richter, Rachel L Jampsa, Gail P Jarvik, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 10, 2003
Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicityLucio G Costa, Rebecca J Richter, Wan-Fen Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2008
Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoningRichard C Stevens, Stephanie M Suzuki, Toby B Cole, et al.
Pharmacogenetics|May 2, 2003
Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 statusGail P Jarvik, Rachel Jampsa, Rebecca J Richter, et al.
Pageof 3